BioCentury
ARTICLE | Company News

Avedro's ophthalmic solution gets Priority Review

November 26, 2013 1:20 AM UTC

Avedro Inc. (Waltham, Mass.) said FDA accepted and granted Priority Review to an NDA for riboflavin ophthalmic solution to treat keratoconus (structural degradation of the cornea) and corneal ectasia ...